Cough, Cold and Allergy (Hay Fever) Remedies in the US

Euromonitor International
April 3, 2012
54 Pages - SKU: EP4960218
Countries covered: United States

In 2011, Chattem Inc’s Allegra brand of antihistamine/allergy remedies (systemic) switched from Rx-to-OTC, representing one of the largest switches in the segment’s history. First stocked on store shelves in March, Chattem accompanied Allegra’s launch with significant promotional spending both in-store and via media outlets. Attractive end-caps and displays at major retailers heralded the brand’s switch, while television and online advertisements appeared with great frequency. With its switch...

Euromonitor International's Cough, Cold and Allergy (Hay Fever) Remedies in USA report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2007-2011, allowing you to identify the sectors driving growth. Forecasts to 2016 illustrate how the market is set to change.

Product coverage: Antihistamines/Allergy Remedies (Systemic), Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies, Cough Remedies, Decongestants, Medicated Confectionery, Paediatric Cough, Cold and Allergy Remedies, Pharyngeal Preparations.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
  • Get a detailed picture of the Cough, Cold and Allergy (Hay Fever) Remedies market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.



More Allergy/Immunology reports by Euromonitor International

Cough, Cold and Allergy (Hay Fever) Remedies - Taiwan by Euromonitor International
Cough, Cold and Allergy (Hay Fever) Remedies in TaiwanSteady value growth in cough, cold and allergy (hay fever) remedies at under 4% was recorded for ...
Cough, Cold and Allergy (Hay Fever) Remedies - Brazil by Euromonitor International
Cough, Cold and Allergy (Hay Fever) Remedies in BrazilCough, cold and allergy (hay fever) remedies registered a healthy performance during 2013, following the same path ...
Cough, Cold and Allergy (Hay Fever) Remedies - New Zealand by Euromonitor International
Cough, Cold and Allergy (Hay Fever) Remedies in New ZealandConsumer demand for seasonal cold/flu ailments kept cough, cold and allergy (hay fever) remedies buoyant during ...
Cough, Cold and Allergy (Hay Fever) Remedies - Hong Kong, China by Euromonitor International
Cough, Cold and Allergy (Hay Fever) Remedies in Hong Kong, ChinaLiving conditions in Hong Kong result in a high incidence of coughs, colds and allergies. ...
See all reports like this >>

More United States Allergy/Immunology reports

Pharmaceuticals: Cough, Cold and Allergy (Hay Fever) Remedies in the US by Euromonitor International
Pharmaceuticals: Cough, Cold and Allergy (Hay Fever) Remedies in the USThe relatively mild winter in 2012 provided a sharp juxtaposition to 2013, where the allergy ...
OTC Pharmaceuticals: Cough, Cold and Allergy (Hay Fever) Remedies in the US by Euromonitor International
OTC Pharmaceuticals: Cough, Cold and Allergy (Hay Fever) Remedies in the USThe relatively mild winter in 2012 provided a sharp juxtaposition to 2013, where the ...
Cough & Cold Medicine Manufacturing OTC - Industry Market Research Report - in the US by IBISWorld
Cough & Cold Medicine Manufacturing OTCThe nondiscretionary nature of cough and cold medicine will support stable industry growth, as people consistently contract viruses. Operators will ...
Market Highlights: US Sinusitis – 2014 by Fore Pharma
US Sinusitis Market Highlights – 2014The latest research, 'US Sinusitis Market Highlights – 2014', provides the US sinusitis market analysis, competitive landscape, and sinusitis drug ...
See all reports like this >>

More United States reports

The 2013-2018 Outlook for Collagen and (hyaluronic Acid) HA-Based Biomaterials in the United States by Icon Group International, Inc.
The 2013-2018 Outlook for Collagen and (hyaluronic Acid) HA-Based Biomaterials in the United StatesThis econometric study covers the latent demand outlook for collagen and (hyaluronic ...
The 2013-2018 Outlook for Relish in the United States by Icon Group International, Inc.
This econometric study covers the latent demand outlook for relish across the states and cities of the United States. Latent demand (in millions of U.S. ...
D&B Country RiskLine Report: The United States of America by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...
D&B Country Report: The United States of America by Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...
See all reports like this >>

 

SELECT A LICENSE

    Online Download  USD 900  
    Global Site License  USD 2,700  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!